Switglim-M 2/500 Tablet PR
By Switglim-M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg)

Manufacturer - Akumentis Healthcare Ltd
204, 2nd Floor, G-Corp Tech Park, Kasarvadavali, Near Hypercity, Ghodbandar Road, Thane (West) - 400615. ,Maharashtra, India

Expires on or after
November, 2025

liver
Switglim-M 2/500 Tablet PR should be used carefully by individuals with liver disease. Adjusting the dose of Switglim-M 2/500 Tablet PR may be necessary, so it's vital to seek advice from your healthcare provider. Typically, Switglim-M 2/500 Tablet PR is initiated at a low dosage for those with mild to moderate liver issues. However, it is advised to avoid using this medication in individuals with severe liver disease. If you have liver concerns, consult your doctor before using Switglim-M 2/500 Tablet PR.

kidney
Caution should be exercised with Switglim-M 2/500 Tablet PR in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor. Avoid use in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Switglim-M 2/500 Tablet PR.

driving
When taking Switglim-M 2/500 Tablet PR, avoid driving if you experience low or high blood sugar symptoms that can affect your ability to drive safely.

pregnancy
Switglim-M 2/500 Tablet PR may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor, as they will assess the risks and benefits before prescribing this medication to you.

breastfeeding
Switglim-M 2/500 Tablet PR should be avoided during breastfeeding due to potential harm to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹70.34
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024